Morpholine derivatives as norepinephrine reuptake inhibitors

Details Morpholine derivatives as norepinephrine reuptake inhibitors Morpholine derivatives as norepinephrine reuptake inhibitors

2004-10-28

2008-09-09

Anderson, Rebecca L (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S149000

Reexamination Certificate

active

07423037

ABSTRACT:
Compounds of the general formula (I) are inhibitors of the reuptake of norepinephrine. As such, they may be useful for the treatment of disorders of the central and/or peripheral nervous system.

REFERENCES:
patent: 7354920 (2008-04-01), Cases-Thomas
patent: 2 852 954 (2004-10-01), None
patent: 2004 277318 (2004-10-01), None
patent: WO 99/37305 (1999-07-01), None
patent: WO 01/00214 (2001-01-01), None
patent: WO 01/01973 (2001-01-01), None
patent: WO 03/018576 (2003-03-01), None
patent: WO 2004/018441 (2004-03-01), None
patent: WO 2004/087647 (2004-10-01), None
Morilak et al., Progress in Neuro-Psychopharmacology & Biology Psychiatry, 29(2005), pp. 1214-1224.
Kato, Shiro, et al., “1-(1-Substituted-4-piperidinylmethyl)piperidine derivatives as 5-TH4 receptor agonists, pharmaceutical compositions containing them, and their use,” XP002317575, Database CA 'Online! Chemical Abstracts Service, Columbus, Ohio, US, retrieved from STN Database accession No. 2004:819908 abstract.
King, Frank, et al., “The synthesis of 2-morpholinecarboxylic acid derivatives and their elaboration to 1-aza-4-oxabicyclo′3.3.1!nonan-6-one”,Tetrahedron Letters, 32(20):2281-4, 1991.

Affiliated with

Also associated with

Rating

Morpholine derivatives as norepinephrine reuptake inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Morpholine derivatives as norepinephrine reuptake inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morpholine derivatives as norepinephrine reuptake inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3976772